Sign in to continue:

Thursday, March 5th, 2026

WesBanco, Inc. 8-K SEC Filing March 2026 – Company Details, Stock Information, and Entity Data

WesBanco, Inc. Files 8-K: Key Executive Changes and Shareholder Information

WesBanco, Inc. Files 8-K: Key Executive Changes and Shareholder Information

Key Points from the 8-K Filing

  • Filing Date: March 4, 2026
  • Form Type: 8-K (Current Report)
  • Company: WesBanco, Inc.
  • Trading Symbols:
    • Common Stock: WSBC (Nasdaq Global Select Market)
    • Depositary Shares (Series B Preferred): WSBCO (Nasdaq Global Select Market)
  • Subject: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • Not an Emerging Growth Company

Details of the Filing

WesBanco, Inc. has filed a Form 8-K with the Securities and Exchange Commission to notify shareholders and the investing public about material changes in its executive team. The filing, made on March 4, 2026, specifically addresses the departure, election, or appointment of directors and certain officers, as well as any compensatory arrangements involving these officers.

The filing confirms that WesBanco is not an “Emerging Growth Company” and does not use the extended transition period for complying with any new or revised financial accounting standards.

What Shareholders Need to Know

  • Executive Changes: The 8-K is filed under Item 5.02, which is specifically reserved for events such as the resignation, retirement, or termination of directors or certain executive officers, or the appointment of new individuals to these roles. This is a potentially price-sensitive disclosure, as changes in executive leadership can have a direct impact on company direction, strategy, and investor confidence.
  • Compensatory Arrangements: The filing also covers any compensatory arrangements—such as new employment agreements, bonuses, stock options, or other incentive plans—offered to newly appointed executives or directors, or changes to existing ones. Such arrangements can affect the company’s expenses and signal management’s commitment to attracting or retaining top talent.
  • No Simultaneous Satisfaction of Other Regulatory Filings: The company explicitly states that this 8-K is not intended to simultaneously satisfy the filing obligations under Rules 425 (written communications related to business combinations), 14a-12 (soliciting material), 14d-2(b), or 13e-4(c) (pre-commencement tender or issuer tender offers). This means the focus is squarely on internal governance changes.
  • Registered Securities:
    • Common Stock (\$2.0833 Par Value) is traded under the symbol WSBC on Nasdaq Global Select Market.
    • Depositary Shares (each representing 1/40th interest in a share of 7.375% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B) are traded under the symbol WSBCO on Nasdaq Global Select Market.
  • Authorized Signatory: The filing is signed by Daniel K. Weiss, Jr., Senior Executive Vice President and Chief Financial Officer, indicating the company’s commitment to transparency and regulatory compliance.

Potential Impact on Share Value

Executive transitions and changes in compensation arrangements are typically closely watched by investors. Such events can signal shifts in company strategy, leadership philosophy, or financial stewardship, all of which can directly impact investor sentiment and the company’s share price. Shareholders should carefully monitor further communications from the company, especially if names or details of departing or incoming executives are disclosed in subsequent filings or press releases.

Other Noteworthy Information

  • The company is headquartered at 1 Bank Plaza, Wheeling, West Virginia, with a business phone number of (304) 234-9000.
  • There are no amendments (the Amendment Flag is marked “false”), indicating this is an original filing rather than a correction or update of a previous one.

Conclusion

While the filing itself does not disclose specific names or the nature of executive changes, the fact that WesBanco, Inc. is reporting under Item 5.02 is significant. Investors should stay alert for further updates, as the details of any executive departures, appointments, or changes to compensation could meaningfully affect the company’s trajectory and market valuation.


Disclaimer: This article is for informational purposes only. It is not investment advice or a recommendation to buy or sell any security. Investors should conduct their own research and consult with their financial advisors before making investment decisions based on SEC filings or any other public disclosure.


View WESBANCO INC Historical chart here



Hamilton Beach Brands Holding Company 2025 Annual Report: Business Overview, Risk Factors, and Corporate Governance

Hamilton Beach Brands Holding Company 2025 Annual Report – Key Highlights for Investors Hamilton Beach Brands Holding Company 2025 Annual Report: Detailed Investor Insights Key Points from the 2025 Annual Report Business Overview: Hamilton...

AbbVie Inc. Supplemental Indenture: Details on 2028, 2031, 2033, 2036, 2056, 2066 Senior Notes and Floating Rate Notes

AbbVie Inc. Completes Major \$7.5 Billion Senior Notes Offering Key Highlights: AbbVie Inc. completed a massive underwritten public offering of senior notes, raising an aggregate principal amount of \$7.5 billion. The offering includes multiple...

Amarin Corporation plc 2025 Annual Report: Company Overview, Financials, and SEC Filings

Amarin Corporation plc 2025 Annual Report: Key Investor Insights Amarin Corporation plc 2025 Annual Report: Detailed Investor Analysis Key Highlights from the 2025 Annual Report Fiscal Year End: December 31, 2025 Company Structure: Amarin...

   Ad